Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Molecularly Driven Pilot Study of Preoperative Ganetespib in Resectable Squamous Cell Carcinoma of the Head and Neck (SCCHN)

NCT02334319 is registered in ClinicalTrials.gov with Emory University as lead sponsor.

NCT NCT02334319
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02334319 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Molecularly Driven Pilot Study of Preoperative Ganetespib in Resectable Squamous Cell Carcinoma of the Head and Neck (SCCHN)
Lead sponsor
Emory University
Phase
Phase 1
Overall status
Terminated
Start date
December 31, 2014
Completion date
February 29, 2016
Enrollment
3 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

stage i hypopharyngeal squamous cell carcinoma, stage i laryngeal squamous cell carcinoma, stage i oral cavity squamous cell carcinoma, stage i oropharyngeal squamous cell carcinoma, stage ii hypopharyngeal squamous cell carcinoma, stage ii laryngeal squamous cell carcinoma, stage ii oral cavity squamous cell carcinoma, stage ii oropharyngeal squamous cell carcinoma, stage iii hypopharyngeal squamous cell carcinoma, stage iii laryngeal squamous cell carcinoma, stage iii oral cavity squamous cell carcinoma, stage iii oropharyngeal squamous cell carcinoma, stage iva hypopharyngeal squamous cell carcinoma, stage iva laryngeal squamous cell carcinoma, stage iva oral cavity squamous cell carcinoma, stage iva oropharyngeal squamous cell carcinoma